Abiomed, Inc.
Abiomed, Inc., a leading player in the cardiovascular medical device industry, is headquartered in the United States. Founded in 1981, the company has made significant strides in developing innovative heart pump technologies, particularly in the areas of heart recovery and circulatory support. With a focus on products such as the Impella heart pump, Abiomed has distinguished itself through its commitment to improving patient outcomes and advancing heart care. The company operates primarily in North America and Europe, positioning itself as a pioneer in minimally invasive heart pump solutions. Notable achievements include the FDA approval of its devices, which have transformed the treatment landscape for patients with severe coronary artery disease. Abiomed continues to lead the market with its cutting-edge technology and dedication to enhancing the quality of life for patients worldwide.
DitchCarbon Score
How does Abiomed, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Abiomed, Inc.'s score of 18 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Abiomed, Inc.'s reported carbon emissions
Abiomed, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their climate impact or commitments. However, the company is likely aware of the growing importance of sustainability in the medical device industry and may be exploring initiatives to address climate change. As the industry evolves, Abiomed may consider setting measurable targets to reduce their carbon footprint and align with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Abiomed, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
